Company facts
- Headquarters
- Gaithersburg, Maryland
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1000694
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 58
News 8 of 211
Prospectuses and Registrations 8 of 46
- S-8 Registration statement for an employee plan Aug 6, 2026
- S-8 Registration statement for an employee plan Aug 8, 2024
- S-8 Registration statement for an employee plan Aug 8, 2023
- 424B5 Prospectus supplement for an offering Aug 8, 2023
- S-3ASR Automatic shelf registration Feb 28, 2023
- S-8 Registration statement for an employee plan Jan 20, 2023
- 424B5 Prospectus supplement for an offering Dec 19, 2022
- FWP Free writing prospectus Dec 16, 2022
Proxies 8 of 43
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Jun 5, 2024
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Jul 7, 2023
Ownership 8 of 593
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
- 4 Insider reported a trade Jun 23, 2026
Other 8 of 49
Everything here comes from Novavax Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.